Phase II study of preoperative Docetaxel, cisplatin and S-1 in patients with clinically respectable type 4 , large type 3 and with extensive lymph node metastasis gastric cancer
Not Applicable
- Conditions
- Gastric cancer
- Registration Number
- JPRN-UMIN000003052
- Lead Sponsor
- Department of Surgery, Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Active malignancy in other organ 2)Serious complications 3)Acute inflammation 4)Allergy or hyper sensitivity to any drugs 5)Motor weakness or peripheral nerve disorder 6)With pleural or cardiac effusion 7)Pregnant or breast feeding 8)Interstitial pneumonia or pulmonary fibrosis 9)Psychological disease which require treatment 10)Hypersensitivity to S1 or CDDP or TXT 11)Systemic administration of other fluorouracil 12)Administration of flucytocine 13)Patients judged inappropriate for the study by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pathological response
- Secondary Outcome Measures
Name Time Method